当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:535.98亿  总市值:675.62亿
流通股本:21.18亿   总股本:26.70亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金10,036,720,780.242,051,276,895.930,773,141,374.9120,208,100,300.64
  收到的税费返还120,411,573.95383,454,967.68253,122,403.14184,554,340.78
  收到其他与经营活动有关的现金947,760,302.74880,686,797.761,185,817,322.69996,338,870.54
  经营活动现金流入小计11,104,892,656.8943,315,418,661.3432,212,081,100.7421,388,993,511.96
  购买商品、接受劳务支付的现金3,339,525,252.6214,670,081,647.9811,176,691,619.617,145,888,018.58
  支付给职工以及为职工支付的现金3,197,848,208.0811,245,753,461.998,507,722,635.455,929,869,192.95
  支付的各项税费686,177,071.612,674,701,462.592,054,188,939.251,464,706,738.36
  支付其他与经营活动有关的现金2,732,744,336.769,511,655,210.437,091,709,340.724,714,529,067.76
  经营活动现金流出小计9,956,294,869.0738,102,191,782.9928,830,312,535.0319,254,993,017.65
  经营活动产生的现金流量净额1,148,597,787.825,213,226,878.353,381,768,565.712,134,000,494.31
二、投资活动产生的现金流量:
  收回投资收到的现金347,569,016.662,450,861,304.172,217,629,391.751,625,743,729.78
  取得投资收益收到的现金122,511,415.01792,055,953.78226,566,471.52134,793,660.86
  处置固定资产、无形资产和其他长期资产收回的现金净额43,817,389.5981,902,433.5242,136,833.161,924,563.54
  处置子公司及其他营业单位收到的现金净额65,841,904.03230,623,552181,376,314.58172,736,314.58
  收到的其他与投资活动有关的现金10,550,546.86166,815,422.57220,302,827.7777,465,182.17
  投资活动现金流入小计590,290,272.153,722,258,666.042,888,011,838.782,012,663,450.93
  购建固定资产、无形资产和其他长期资产支付的现金1,091,365,638.924,448,451,634.913,168,540,323.032,073,906,530.23
  投资支付的现金671,162,856.2937,720,065.36892,030,051.91544,580,781.77
  取得子公司及其他营业单位支付的现金297,095,544.2533,976,446.733,976,446.7-
  支付其他与投资活动有关的现金259,950,736.18447,876,807.8305,297,457.93253,913,153.89
  投资活动现金流出小计2,319,574,775.555,868,024,954.774,399,844,279.572,872,400,465.89
  投资活动产生的现金流量净额-1,729,284,503.4-2,145,766,288.73-1,511,832,440.79-859,737,014.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金25,032,000218,263,053.21195,288,551.57134,789,848.57
  其中:子公司吸收少数股东投资收到的现金25,032,000218,263,053.21195,288,551.57134,789,848.57
  取得借款收到的现金7,821,034,931.6336,258,205,827.7426,346,546,129.0816,192,026,243.13
  收到其他与筹资活动有关的现金107,291,170.84857,550,499.2327,480,095.01521,751,778.55
  筹资活动现金流入小计7,953,358,102.4737,334,019,380.1526,869,314,775.6616,848,567,870.25
  偿还债务支付的现金6,317,691,422.1136,493,980,610.5426,629,633,045.3116,176,838,838.91
  分配股利、利润或偿付利息支付的现金250,088,995.612,315,321,975.782,060,586,501.09777,894,219.56
  其中:子公司支付给少数股东的股利、利润7,727,047.95370,679,415.07351,893,007.84180,177,918.91
  支付其他与筹资活动有关的现金107,382,486.231,768,806,300.981,423,521,850.451,354,035,085.6
  筹资活动现金流出小计6,675,162,903.9540,578,108,887.330,113,741,396.8518,308,768,144.07
  筹资活动产生的现金流量净额1,278,195,198.52-3,244,089,507.15-3,244,426,621.19-1,460,200,273.82
四、汇率变动对现金及现金等价物的影响-158,570,564.25-176,810,748.88-80,826,833.379,762,529.4
五、现金及现金等价物净增加额538,937,918.69-353,439,666.41-1,455,317,329.64-176,174,265.07
  加:期初现金及现金等价物余额9,038,010,120.79,391,449,787.119,391,449,787.119,391,449,787.11
  期末现金及现金等价物余额9,576,948,039.399,038,010,120.77,936,132,457.479,215,275,522.04
补充资料:
  净利润-4,247,929,628.38-2,100,210,564.8
  资产减值准备-150,063,042.97-64,269,906.34
  固定资产和投资性房地产折旧-1,782,627,838.46-773,788,060.53
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,782,627,838.46-773,788,060.53
  无形资产摊销-1,362,330,066.18-632,373,736.11
  长期待摊费用摊销-211,406,402.92-103,945,371.05
  处置固定资产、无形资产和其他长期资产的损失--69,350,406.88--2,116,774.07
  固定资产报废损失-9,848,475.82-5,430,528.51
  公允价值变动损失-322,268,457.29-48,596,693.14
  财务费用-1,109,132,867.54-556,338,581.92
  投资损失--3,763,778,024.02--2,120,176,697.39
  递延所得税--326,000,447.95-159,056,091.8
  其中:递延所得税资产减少--253,876,291.87-7,946,457.27
    递延所得税负债增加--72,124,156.08-151,109,634.53
  存货的减少-1,236,227,214.47-490,624,923.63
  经营性应收项目的减少--1,011,067,423.03--421,230,400.73
  经营性应付项目的增加--748,906,006.61--479,697,287.52
  不涉及现金收支的投资和筹资活动金额其他项目-1,066,676,562.95--
  现金的期末余额-9,038,010,120.7-9,215,275,522.04
  减:现金的期初余额-9,391,449,787.11-9,391,449,787.11
  现金及现金等价物的净增加额--353,439,666.41--176,174,265.07
公告日期2026-04-292026-03-252025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑